For in vitro diagnostic use. Others Elecsys Troponin T hs STAT IVD Elecsys® Troponin T hs STAT CPS_000531 05092728190 Troponin T hs STAT Elecsys cobas e 100 Elecsys Troponin T hs STAT 04015630925353 Reagents, kits 100 tests cobas e 411/601/602 true 09315349190 TnT hs STAT Elecsys cobas e100 V2.1 Elecsys Troponin T hs STAT 07613336191590 Reagents, kits 100 tests cobas e 411/601/602 true 08469814190 Troponin T hs STAT Elecsys cobas e100 V2 Elecsys Troponin T hs STAT 07613336158937 Reagents, kits 100 tests cobas e 411/601/602 true 09315349500 Elecsys Troponin T hs STAT en 3 FF0000000662050E FF000000047CE30E 09315349190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin T in human serum and plasma. This assay can be used as an aid in the differential diagnosis of acute coronary syndrome to identify necrosis e.g. acute myocardial infarction (AMI), and as an aid for early discharge and outpatient management for patients suspected of acute coronary syndrome (ACS). The test is further indicated for the risk stratification of patients presenting with acute coronary syndrome and for cardiac risk in patients with chronic renal failure. The test may also be useful for the selection of more intensive therapy and intervention in patients with elevated levels of cardiac troponin T (cTnT).In addition, this test can be used in the context of non‑cardiac surgeries to predict pre‑operatively the perioperative risk of major adverse cardiac events and in diagnosis of perioperative myocardial infarction (PMI) and myocardial injuries after non-cardiac surgeries (MINS).The cTnT‑hs values may also be used, in conjunction with clinical and diagnostics findings, to aid in stratifying the long-term risk of cardiovascular death, myocardial infarction, coronary revascularization, heart failure or ischemic stroke, and all-cause mortality in asymptomatic individuals.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08469814500 Elecsys Troponin T hs STAT en 5 FF00000005639A0E FF0000000356690E 08469814190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin T in human serum and plasma. This assay can be used as an aid in the differential diagnosis of acute coronary syndrome to identify necrosis, e.g. acute myocardial infarction. The test is further indicated for the risk stratification of patients presenting with acute coronary syndrome and for cardiac risk in patients with chronic renal failure. The test may also be useful for the selection of more intensive therapy and intervention in patients with elevated levels of cardiac troponin T.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en